The DOI matches its Crossref record.
The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility
Open accessAbstract
Alpha-glycerylphosphorylcholine (Alpha-GPC) and caffeine supplementation have been shown to improve mental and physical performance. Alpha-GPC administration increases the release of the neurotrans...
Overview
CoChat Summary
TL;DR
In a randomized, double-blind, placebo-controlled crossover trial, acute supplementation with 200 mg or 400 mg alpha-glycerylphosphorylcholine (Alpha-GPC) or 200 mg caffeine produced no statistically significant benefits on mood, cognitive function, or physiological performance versus placebo. The authors attribute the null findings largely to large individual variability between subjects.
Key findings
- Serial subtraction test (SST) times were 18.1% faster with low-dose Alpha-GPC (aGPC-L, 6.19 ± 2.21 s) than caffeine (CA, 7.32 ± 5.67 s) and 10.5% faster than placebo (PL, 6.85 ± 2.52 s).
- Vertical jump peak power was 8.5% higher with aGPC-L (2,041.3 ± 547.2 W), 7.5% higher with high-dose Alpha-GPC (aGPC-H, 2,023.1 ± 942.8 W), and 2.0% higher with caffeine (1,920.4 ± 689.6 W) versus placebo (1,881.9 ± 576.9 W).
- Caffeine produced significantly higher visual analog scale (VAS) jitteriness scores than aGPC-H (p = 0.019), but not versus aGPC-L (p = 0.849) or placebo (p = 0.086).
- No other statistically significant differences between supplement groups were found for any dependent variable.
Methods
- Twenty participants (10 males, 10 females; 22.0 ± 3.4 years; height 171.9 ± 7.4 cm; weight 56.8 ± 8.6 kg) completed a randomized, double-blind, placebo-controlled crossover design.
- Conditions were 200 mg Alpha-GPC (aGPC-L), 400 mg Alpha-GPC (aGPC-H), 200 mg caffeine (CA), and placebo (PL).
- Measurements taken 30 minutes post-supplementation: VAS for six moods, a serial subtraction test, and tests of reaction time, hand-eye coordination, power, speed, and agility.
Limitations
- The paper states that large individual variability between subjects contributed to the lack of significant effects, and recommends future research address dosage, timing of consumption before testing, bioavailability, longer-term supplementation, and subject selection.
- Evident from the text: this is a conference abstract with no reported statistical detail beyond selected p-values, no effect sizes or confidence intervals, and no description of the specific power, speed, agility, or coordination tests or their results.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 0 Not valid · 0 Not checked · 13 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The group consuming CA had significantly higher scores on the VAS for jitteriness compared to aGPC-H (p = 0.019), but not aGPC-L (p = 0.849) or PL (p = 0.086).”
§ The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The group consuming CA had significantly higher scores on the VAS for jitteriness compared to aGPC-H (p = 0.019), but not aGPC-L (p = 0.849) or PL (p = 0.086).”
§ The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Vertical Jump Peak Power was 8.5% higher in the aGPC-L (2,041.3 ± 547.2 W), 7.5% higher in the aGPC-H (2,023.1 ± 942.8 W) and 2.0% higher in the CA group (1,920.4 ± 689.6 W) in comparison to PL (1,881.9 ± 576.9 W).”
§ The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SST scores were 18.1% and 10.5% faster in the aGPC-L (6.19 ± 2.21 s) group compared to CA (7.32 ± 5.67 s) and PL (6.85 ± 2.52 s), respectively.”
§ The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The group consuming CA had significantly higher scores on the VAS for jitteriness compared to aGPC-H (p = 0.019), but not aGPC-L (p = 0.849) or PL (p = 0.086).”
§ The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
7 more claims
Create a free account to see all 13 claims and every source verdict.
- Probably not a substantial claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This study, however, used smaller doses of A-GPC (200 mg, 400 mg) administered acutely 30 min before the performance assessments and additionally did not use forceplate based performance assessments.”
From Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, a recent study [17] with a similar design that compared two doses of A-GPC with placebo and caffeine did not demonstrate any significant increases in performance.”
From Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance (2017) · cites this paper as [17]
Citations
Cited by
The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength
Bellar, D., LeBlanc, N. R., & Campbell, B. (2015) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-015-0103-x · Cited by 43
Marcus, L., Soileau, J., Judge, L. W., & Bellar, D. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0196-5 · Cited by 36
“However, a recent study [17] with a similar design that compared two doses of A-GPC with placebo and caffeine did not demonstrate any significant increases in performance.”
ResultNemati, J., Hemmatinafar, M., Niknam, A., Nikahd, M., Zeighami, N., Imanian, B., Safari, K., Jahaniboushehri, N., & Suzuki, K. (2023) · Nutrients · doi:10.3390/nu15184049 · Cited by 28
Zhou, C., Yan, H., Yang, W., & Hu, Y. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.115998 · Cited by 16
Saccharomyces cerevisiae Fermentation of 28 Barley and 12 Oat Cultivars
Tse, T. J., Wiens, D. J., Shen, J., Beattie, A. D., & Reaney, M. J. T. (2021) · Fermentation · doi:10.3390/fermentation7020059 · Cited by 13
Metadata
- Authors
- Parker, A. G., Byars, A., Purpura, M., & Jäger, R.
- Affiliations
- Angelo State University (US)
- Increnovo LLC (United States) (US)
- Corresponding author
- Parker, Adam G
- Venue
- Journal of the International Society of Sports Nutrition
- Publisher
- Informa UK Limited
- Published
- 2015-09-21
- Volume
- 12
- Issue
- sup1
- ISSN
- 1550-2783 (ISSN-L)
- PMC
- PMC4595381
- OpenAlex
- W1962071880
- Cited by
- 18
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2021: 2 · 2019: 3 · 2018: 3 · 2017: 1 · 2015: 1
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the International Society of Sports Nutrition (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- caffeine, mood, cognitive function, power, sprint speed, agility, placebo, dietary supplementation, neurotransmitter release
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility. https://app.cochat.ai/papers/10.1186/1550-2783-12-s1-p41
- The paper
- Parker, A. G., Byars, A., Purpura, M., & Jäger, R. (2015). The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility. Journal of the International Society of Sports Nutrition. https://doi.org/10.1186/1550-2783-12-s1-p41
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
